UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022884 |
|---|---|
| Receipt number | R000025498 |
| Scientific Title | Phase II study of regorafenib with dose adjustment and pharmacokinetic analysis in advanced colorectal cancer |
| Date of disclosure of the study information | 2016/08/01 |
| Last modified on | 2020/02/18 08:34:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/06/25 16:59:53 | ||
| 2 | Update | 2016/08/23 20:43:00 | Recruitment status |
|
| 3 | Update | 2018/01/16 10:33:38 | Recruitment status Last follow-up date |
|
| 4 | Update | 2018/06/23 16:50:36 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 5 | Update | 2018/06/27 11:24:35 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 6 | Update | 2018/12/30 12:15:36 | Date analysis concluded |
|
| 7 | Update | 2020/02/18 08:22:00 | Recruitment status Date of IRB |
|
| 8 | Update | 2020/02/18 08:34:41 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
